Bayer AG Stock Deutsche Boerse AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Deutsche Boerse AG 11:57:22 2024-04-19 am EDT 5-day change 1st Jan Change
26.3 EUR +0.81% Intraday chart for Bayer AG -2.67% -21.97%
Sales 2024 * 47.23B 50.31B Sales 2025 * 48.12B 51.26B Capitalization 25.86B 27.55B
Net income 2024 * 2.36B 2.51B Net income 2025 * 3.21B 3.42B EV / Sales 2024 * 1.24 x
Net Debt 2024 * 32.81B 34.95B Net Debt 2025 * 29.7B 31.64B EV / Sales 2025 * 1.15 x
P/E ratio 2024 *
11.4 x
P/E ratio 2025 *
7.99 x
Employees 96,931
Yield 2024 *
1.3%
Yield 2025 *
1.43%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.81%
1 week-2.67%
Current month-7.61%
1 month+1.66%
3 months-19.08%
6 months-37.73%
Current year-21.97%
More quotes
1 week
25.67
Extreme 25.665
27.05
1 month
25.67
Extreme 25.665
28.90
Current year
24.98
Extreme 24.98
36.00
1 year
24.98
Extreme 24.98
61.08
3 years
24.98
Extreme 24.98
67.95
5 years
24.98
Extreme 24.98
79.00
10 years
24.98
Extreme 24.98
146.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23-03-31
Director of Finance/CFO 54 18-04-25
Chief Tech/Sci/R&D Officer 55 20-03-31
Members of the board TitleAgeSince
Director/Board Member 68 17-03-31
Director/Board Member 68 17-03-31
Director/Board Member 67 21-03-31
More insiders
Date Price Change Volume
24-04-19 26.3 +0.81% 7,113
24-04-18 26.08 -0.99% 8,299
24-04-17 26.34 +0.19% 5,660
24-04-16 26.3 -0.32% 10,452
24-04-15 26.38 -2.35% 20,812

Delayed Quote Deutsche Boerse AG, April 19, 2024 at 11:57 am EDT

More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.32 EUR
Average target price
37.05 EUR
Spread / Average Target
+40.73%
Consensus